publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
apic
research
foundat
rf
goal
improv
practic
infect
control
realiz
financi
support
research
dissemin
research
peerreview
journal
advocaci
import
infect
prevent
control
area
health
care
issu
two
articl
contribut
dissemin
research
result
practic
guidelin
apic
rf
select
individu
present
annual
state
scienc
lectur
synthesi
recent
research
field
infect
control
appli
epidemiolog
follow
articl
summar
sentinel
scientif
publicationsreport
past
year
kimberli
clark
grant
apic
rf
support
lectur
scienc
practic
present
provid
profession
forum
review
clinic
research
practic
guidelin
implement
best
outcom
grant
apic
rf
support
symposium
articl
base
present
made
full
implement
best
evidencebas
scienc
health
care
epidemiolog
infect
control
essenti
patient
outcom
optim
health
care
cost
minim
rapid
expans
health
care
epidemiolog
infect
control
patient
safeti
literatur
increasingli
difficult
stay
date
latest
scienc
field
identifi
promptli
implement
lifesav
prevent
intervent
guidelin
recommend
prevent
health
careassoci
infect
hai
publish
period
often
import
prevent
measur
advanc
scienc
occur
guidelin
updat
may
brought
attent
infect
control
personnel
icp
purpos
state
scienc
present
annual
meet
associ
profession
infect
control
epidemiolog
inc
apic
review
latest
scientif
advanc
field
year
bring
find
attent
infect
control
commun
paper
summar
advanc
state
scienc
health
care
epidemiolog
infect
control
patient
safeti
last
year
period
guidelin
publish
guidelin
provid
import
recommend
prevent
health
careassoci
pneumonia
environment
infect
control
infect
control
dental
set
control
prevent
antimicrobialresist
pathogen
prevent
infect
associ
endoscopi
icp
read
guidelin
implement
highli
support
evidencebas
recommend
contact
isol
realli
reduc
transmiss
antimicrobialresist
pathogen
question
address
lepelleti
et
al
studi
hospit
franc
period
focus
analysi
methicillinresist
staphylococcu
aureu
mrsa
enterobacteriaca
resist
intermedi
suscept
thirdgener
cephalosporin
pseudomona
aeruginosa
acinetobact
spp
resist
ticarcillin
ceftazidim
andor
imipenem
routin
clinic
cultur
use
detect
pathogen
activ
surveil
cultur
perform
extens
educ
effort
includ
meet
train
staff
meet
discuss
target
pathogen
epidemiolog
transmiss
control
measur
use
hygienist
promot
infect
control
prevent
cross
transmiss
isol
precaut
monitor
patient
includ
intervent
target
multidrugresist
bacteria
increas
studi
period
isol
mrsa
p
aeruginosa
enterobacteriaca
acinetobact
spp
despit
high
complianc
contact
isol
precaut
recommend
ie
isol
sign
alcohol
hand
rub
use
gown
use
glove
use
privat
room
use
mrsa
rate
per
admiss
increas
p
aeruginosa
remain
stabl
enterobacteriaca
increas
author
conclud
prevent
program
mere
fulli
implement
contact
precaut
routin
clinic
cultur
ie
lack
activ
surveil
cultur
suffici
decreas
incid
multidrugresist
bacteria
furthermor
recommend
screen
carriag
multidrugresist
bacteria
highrisk
area
patient
ie
activ
surveil
cultur
togeth
rapid
isol
colon
infect
patient
control
multidrugresist
bacteria
must
precis
term
use
articl
entitl
rapid
control
outbreak
staphylococcu
aureu
neonat
intens
care
depart
use
standard
infect
control
practic
nasal
mupirocin
state
activ
surveil
cultur
addit
cohort
patient
staff
contact
isol
precaut
hand
hygien
nasal
mupriocin
use
intervent
outbreak
termin
week
howev
clear
standard
precaut
alon
use
impli
articl
titl
rather
activ
surveil
cultur
use
addit
contact
precaut
precis
term
use
use
standard
infect
control
practic
paper
reader
misl
confus
interpret
result
often
health
care
worker
hand
becom
contamin
contact
environment
surfac
studi
conduct
veteran
administr
hospit
evalu
often
health
care
worker
hcw
hand
becam
contamin
wardsunit
randomli
select
week
hospit
stool
specimen
posit
clostridium
difficil
screen
vancomycinresist
enterococcu
vre
activ
surveil
cultur
perform
mrsa
target
pathogen
mrsa
vre
c
difficil
gramneg
bacteria
hcw
hand
cultur
immedi
use
alcohol
rub
contact
varieti
environment
surfac
patient
room
ie
bed
rail
bed
tabl
nearbi
surfac
imprint
hand
perform
blood
agar
control
cultur
alcohol
rub
environment
contact
neg
occupi
room
hcw
hand
posit
target
pathogen
clean
room
hcw
hand
posit
target
pathogen
author
conclud
hcw
commonli
acquir
nosocomi
pathogen
contact
environment
surfac
near
patient
contact
isol
paper
reemphas
import
hand
hygien
patient
environment
contact
fecal
incontin
risk
factor
environment
vre
contamin
prospect
studi
univers
hospit
frequenc
vre
contamin
room
contin
incontin
patient
cultur
posit
vre
evalu
cultur
bed
rail
bedsid
tabl
call
button
baselin
day
disinfect
regardless
contin
incontin
statu
without
diarrhea
occasion
frequent
incontin
rate
environment
vre
contamin
common
baselin
day
day
cultur
posit
time
except
day
cultur
contin
patient
without
diarrhea
posit
time
author
conclud
environment
contamin
occur
frequent
room
patient
contin
incontin
vrecolon
similar
infect
control
measur
implement
contin
incontin
patient
studi
show
incontin
risk
factor
environment
vre
contamin
given
data
vre
coloni
count
stool
colon
infect
patient
similar
data
show
infect
control
precaut
implement
vrecolon
infect
patient
whether
contin
incontin
current
factor
argu
aggress
approach
control
health
careassoci
mrsa
vre
past
year
seen
emerg
communityacquir
mrsa
argu
emerg
mrsa
commun
effort
control
mrsa
health
care
set
prioriti
howev
although
preval
communityacquir
mrsa
vari
region
region
sever
studi
show
preval
communityacquir
mrsa
much
much
lower
health
careassoci
mrsa
three
recent
studi
pediatr
popul
third
homeless
popul
found
preval
communityacquir
mrsa
approxim
addit
nation
preval
studi
us
popul
found
preval
mrsa
thu
preval
communityacquir
mrsa
pale
comparison
preval
mrsa
health
care
set
furthermor
past
year
wit
emerg
true
vancomycin
resist
aureu
vrsa
third
vrsainfect
patient
identifi
longterm
care
facil
data
cdc
nation
nosocomi
infect
surveil
nni
system
show
incid
mrsa
vre
continu
increas
health
care
facil
even
facil
icp
commit
infect
control
suggest
current
cdc
isol
guidelin
recommend
work
futur
prevent
transmiss
mrsa
vre
health
care
set
current
incid
mrsa
exce
current
incid
vre
exce
intens
care
unit
icu
set
fig
nni
mrsa
vre
addit
recent
data
monitor
emerg
vre
san
francisco
bay
area
hospit
illustr
aggress
control
measur
taken
vre
becom
endem
institut
hospit
san
francisco
bay
area
vre
increas
isol
hospit
isol
hospit
bloodstream
infect
data
illustr
import
identifi
isol
patient
colon
infect
vre
shea
guidelin
shea
guidelin
prevent
nosocomi
transmiss
multidrugresist
strain
aureu
enterococcu
present
proven
approach
control
mrsa
visa
vrsa
vre
major
recommend
includ
follow
activ
surveil
cultur
identifi
reservoir
ie
colon
patient
spread
hand
hygien
barrier
precaut
contact
isol
cohort
antibiot
stewardship
decolon
mrsaor
vrecolon
patient
hcw
select
set
purpos
activ
surveil
cultur
identifi
colon
patient
guidelin
recommend
patient
admit
hospit
cultur
rather
recommend
highrisk
patient
identifi
exampl
highrisk
patient
might
includ
prolong
antibiot
admit
specif
area
hospit
eg
dialysi
icu
oncolog
ward
underli
diseas
eg
dialysi
patient
prolong
hospit
stay
data
show
shea
guidelin
approach
work
tabl
impact
implement
shea
recommend
approach
varieti
set
entir
acut
care
hospit
univers
commun
hospit
medic
surgic
neonat
icu
surgic
oncolog
ward
shown
intervent
present
shea
annual
meet
shea
recommend
significantli
reduc
mrsa
compar
experi
previou
year
one
instanc
intervent
reduc
mrsa
subsequ
investig
reveal
complianc
surveil
cultur
enhanc
complianc
obtain
activ
surveil
cultur
rate
mrsa
significantli
reduc
personnel
commun
l
mermel
md
seem
extrem
unlik
studi
alreadi
publish
would
find
directionreduct
mrsa
vreif
result
due
chanc
alon
argument
studi
flaw
ring
hollow
similar
data
show
hand
hygien
alon
standard
precaut
alon
implement
current
draft
cdc
hicpac
isol
guidelin
recommend
similar
impact
fact
cdc
nni
data
show
preval
mrsa
vre
continu
increas
despit
implement
cdchicpac
recommend
us
hospit
mathemat
model
tell
us
best
approach
control
vre
recent
perencevich
et
al
publish
studi
use
mathemat
model
icu
data
evalu
varieti
vre
control
strategi
icu
set
model
compar
standard
precaut
activ
surveil
cultur
isol
previous
known
vreposit
patient
readmiss
passiv
surveil
isol
known
vrecultur
posit
admiss
clinic
cultur
detect
vreinfect
patient
ie
cdc
hicpac
approach
activ
surveil
cultur
either
isol
vrecolon
patient
remov
isol
cultur
neg
place
patient
isol
vre
cultur
posit
detect
approach
compar
passiv
surveil
reduc
vre
compar
standard
precaut
alon
contrast
activ
surveil
cultur
isol
patient
cultur
posit
reduc
vre
activ
surveil
cultur
immedi
isol
remov
cultur
neg
reduc
vre
compar
surveil
author
conclud
activ
surveil
project
effect
reduc
vre
transmiss
icu
set
varieti
studi
publish
past
year
infect
control
staf
impact
infect
control
effort
especi
isol
patient
safeti
level
infect
control
profession
staf
necessari
studi
oboyl
et
al
delphi
method
use
survey
icp
determin
staf
requir
infect
control
respond
acut
care
nonacut
care
set
survey
consensu
icp
per
bed
would
requir
perform
expand
function
requir
posit
eg
bioterror
prepared
sar
prepared
occup
health
hivaid
prevent
antimicrobialresist
antimicrobi
use
other
state
infect
control
program
canada
survey
infect
control
program
canada
icp
survey
respond
median
staf
hospit
canada
icp
per
bed
howev
respond
icp
per
bed
addit
doctori
degre
level
person
involv
lack
human
staff
bill
categori
measur
rang
complaint
author
conclud
larg
bodi
studi
support
effect
isol
polici
hospit
prevent
nosocomi
infect
point
although
studi
quasiexperiment
rais
question
whether
group
differ
simpli
function
sever
ill
essenti
essenti
compon
isol
polici
identifi
studi
also
illustr
icp
must
educ
patient
caretak
import
infect
control
practic
complianc
practic
essenti
toler
physician
examin
patient
inconveni
don
appropri
gown
glove
would
toler
surgeon
want
scrub
wear
gown
glove
surgeri
sinc
seen
emerg
spread
west
nile
viru
wnv
east
west
coast
unit
state
although
usual
associ
commun
vectorborn
transmiss
past
month
sever
episod
transmiss
wnvassoci
health
care
first
iwamoto
et
al
describ
transmiss
wnv
organ
donor
transplant
recipi
august
fever
mental
statu
chang
develop
recipi
organ
common
donor
investig
suggest
blood
transfus
probabl
sourc
organ
donor
organ
donor
sourc
infect
recipi
anoth
studi
pealer
et
al
evalu
risk
transmiss
wnv
blood
transfus
examin
patient
identifi
laboratori
confirm
evid
wnv
infect
within
week
receipt
blood
compon
donor
viremia
identifi
patient
confirm
wnv
infect
acquir
transfus
leukoreduc
nonleukoreduc
red
cell
platelet
freshfrozen
plasma
ten
patient
immunocompromis
secondari
transplant
cancer
eight
patient
year
age
immunocompromis
patient
tend
longer
incub
period
donor
link
infect
recipi
report
viral
symptom
donat
fever
new
rash
pain
eye
independ
associ
implic
donor
viremia
wnvspecif
igm
antibodi
neg
time
donat
data
document
transfus
red
cell
platelet
freshfrozen
plasma
transmit
wnv
screen
potenti
donor
use
nucleic
acidbas
assay
wnv
may
reduc
risk
past
month
wit
explos
expans
scienc
relat
sar
first
identif
etiolog
agent
sar
novel
coronaviru
etiolog
agent
detect
use
combin
viru
isol
electron
microscopi
histolog
molecular
serolog
assay
ksaizek
et
al
document
new
syndrom
caus
new
human
coronaviru
sarscov
anoth
studi
isakbaeva
et
al
evalu
potenti
transmiss
laboratori
confirm
sarscovinfect
person
household
contact
perform
longitudin
studi
perform
followup
visit
twice
week
first
week
ill
week
week
case
week
contact
visit
collect
demograph
clinic
epidemiolog
exposur
data
blood
serum
stool
urin
nasopharyng
np
oraophryng
specimen
document
sarscov
detect
sputum
patient
stool
specimen
patient
author
examin
date
onset
locat
resid
assess
probabl
infect
use
logist
regress
patient
build
index
case
build
e
analysi
determin
resid
middl
upper
floor
greater
risk
lower
floor
suggest
possibl
rise
plume
contamin
ward
air
distribut
risk
build
b
c
correspond
well
spread
virusladen
aerosol
predict
comput
fluid
dynam
model
accompani
editori
rais
possibl
need
think
airborn
transmiss
infecti
agent
oblig
preferenti
opportunist
later
happen
amoy
garden
last
studi
evalu
risk
transmiss
sarscov
household
member
hcw
pennsylvania
person
sar
expos
household
member
none
becam
infect
taiwan
patient
sar
expos
hcw
mani
unprotect
exposur
physician
seroconvert
use
surgic
mask
respiratori
protect
past
month
numer
import
advanc
infect
control
health
care
epidemiolog
articl
attempt
highlight
import
larg
number
infect
control
patient
safeti
public
medic
literatur
becom
difficult
keep
current
latest
literatur
highlight
year
advanc
includ
new
nation
intern
guidelin
data
illustr
import
antimicrobialresist
pathogen
critic
need
appli
proven
aggress
control
measur
reduc
infect
slow
advanc
antimicrobialresist
pathogen
vrsa
addit
addit
data
illustr
import
infect
control
program
lack
full
implement
proven
infect
control
measur
last
year
document
wnv
transmit
via
donat
organ
blood
arthropodborn
diseas
convert
hospit
pathogen
last
enorm
amount
scientif
data
provid
etiolog
sar
mode
risk
transmiss
sarscov
incorpor
latest
inform
infect
control
health
care
epidemiolog
implement
effect
proven
method
prevent
high
prioriti
health
care
facil
